Skip to content
Delayed ~15 min

PBLS PARABILIS MEDICINES INC

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Thu 12 Nov 2026 · estimated

What 8 analyst firms say about PARABILIS MEDICINES INC: their latest ratings, price targets and how far the stock is from them. How it works

28.53 USD+0.65 (+2.33%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+45.1%to the avg target 41.40 USD+12.87 USD
Buy 6 · Hold 1 · Sell 0

7 rated views · 8 analyst/firm records · 8 firms

Latest report22 Oct 2026avg report date 28 Jul
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8080
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8074

Recent analyst activity · last 90 days

Our tracked history has 2 reports on PBLS from 2 analyst firms in the last 90 days (8 firms in the past year).

Comparing each firm's latest target with its previous one: 1 has its first observed target in the past year.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Bank of America SecuritiesTazeen AhmadBuy6 Jul 202645.00 USD
Evercore ISIUmer RaffatBuy6 Jul 2026—
GuggenheimMichael SchmidtBuy6 Jul 202640.00 USD
H.C. WainwrightRobert BurnsBuy22 Oct 202640.00 USD
Leerink PartnersAndrew BerensBuy6 Jul 202640.00 USD
Lifesci CapitalCharles ZhuBuy6 Jul 202642.00 USD
Weiss RatingsUnnamed analyst—16 Oct 2026—
Data feed RESEARCHResearch TeamHold7 Jul 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:01 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.